A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

April 19, 2022

Study Completion Date

May 8, 2022

Conditions

Depressive Disorder, Major

Interventions

DRUG

BI 1358894

125 milligram (mg) BI 1358894 taken orally as three film-coated tablets (1x 25mg and 2x 50mg) once a day in the morning for six weeks.

DRUG

Placebo

Placebo matching BI 1358894 taken orally as three film-coated tablets once a day in the morning for six weeks.

Trial Locations (1)

Science 37, Inc., Culver City